Arkolith/Insider Trading/NMTR/Form 4

OrbiMed Israel BioFund GP Limited Partnership

10% Owner9 METERS BIOPHARMA, INC. (NMTR) · full profile →Form 4 · filed May 13, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 11, 2021Option exercise(X)19K$0.62$12K25.7M
May 11, 2021Option exercise(X)13K$0.70$9K25.7M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 11, 2021Option exercise(X)19K—$081K
May 11, 2021Option exercise(X)13K—$038K

Transaction Codes

X
Exercise of in-the-money derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000947871-21-000520) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML